Cargando…
Increased bleeding risk with phosphodiesterase‐5 inhibitors after left ventricular assist device implantation
AIMS: Therapy with phosphodiesterase‐5 inhibitors (PDE5Is) after left ventricular assist device (LVAD) implantation has been associated with lower mortality and device thrombosis but increased risk for post‐operative and gastrointestinal bleeding. We aimed to evaluate the impact of long‐term PDE5Is...
Autores principales: | Jakstaite, Aiste‐Monika, Luedike, Peter, Schmack, Bastian, Pizanis, Nikolaus, Riebisch, Matthias, Weymann, Alexander, Kamler, Markus, Ruhparwar, Arjang, Rassaf, Tienush, Papathanasiou, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318463/ https://www.ncbi.nlm.nih.gov/pubmed/33821578 http://dx.doi.org/10.1002/ehf2.13322 |
Ejemplares similares
-
Phosphodiesterase‐5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure
por: Papathanasiou, Maria, et al.
Publicado: (2023) -
Erectile dysfunction and quality of life in patients under left ventricular assist device support − an unspoken issue
por: Jakstaite, Aiste Monika, et al.
Publicado: (2023) -
Case report: incessant ventricular fibrillation in a conscious left ventricular assist device patient
por: Jakstaite, Aiste Monika, et al.
Publicado: (2021) -
Central extracorporeal circulatory life support (cECLS) in selected patients with critical cardiogenic shock
por: Schmack, Leonie, et al.
Publicado: (2023) -
Introduction of machine perfusion of donor hearts in a single center in Germany
por: Pizanis, Nikolaus, et al.
Publicado: (2023)